TICKERNERD
Menu
ISRGISRGHealthcare · Medical Instruments & Supplies

ISRG Stock Forecast: Intuitive Surgical, Inc. Price Predictions for 2026-2027

Last close, 14 Aug 2026
$395
−1.68% on the day

The 33 Wall Street analysts covering Intuitive Surgical, Inc. hold a median 12-month price target of $483 — +22.4% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 75 of 100 as at 15 Aug 2026 — inside the top quartile. Here, the model and the Street point the same way.

Market cap
$141.3B
Ticker Nerd rank
75 / 100
Median analyst target
$483
Analysts covering
33
Total return, dividends reinvested
1W
+4.1%
1M
+4.0%
YTD
−30.3%
1Y
−17.3%
From 52W high
−33.5%
From 52W low
+18.8%
$332
$593
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

ISRG stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Intuitive Surgical, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 15 Aug 2026
75 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Revisions
94
Quality
94
Issuance
76
Growth
70
Value
68
Volatility
64
Accruals
40
Momentum
30
Size
2

Revisions (94): Analysts have, on balance, been raising their forecasts.

Momentum (30): The shares have been drifting down relative to others.

Size (2): Larger than most of the companies we track — more scrutinised, less often mispriced.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

ISRG stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on ISRG, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$300$400$500$600$700Oct 25Jan 26Apr 26Jul 26ISRGHigh $685Median $483Low $324

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

What Wall Street says33 analysts
23 Buy9 Hold1 Sell
Low $324Median $483High $685

The green dot is the last close — the median target sits +22.4% from it.

Recent analyst actionsNewest first

Of the 20 most recent actions, 0 moved their price target up and 9 moved it down.

DateFirmActionRatingTarget
12 Aug 2026OppenheimerUpgradeOutperform$500
30 July 2026HSBCDowngradeHold$931
30 July 2026HSBCDowngradeHold—
28 July 2026UBSAssumesBuy$550 → $500
17 July 2026BairdMaintainsOutperform$525 → $500
17 July 2026BairdMaintainsOutperform—
17 July 2026BernsteinMaintainsOutperform$750 → $685
17 July 2026BernsteinMaintainsOutperform—
17 July 2026BTIGMaintainsBuy—
17 July 2026BTIGMaintainsBuy$512 → $469
17 July 2026CitigroupMaintainsBuy$590 → $500
17 July 2026CitigroupMaintainsBuy—
17 July 2026Evercore ISI GroupMaintainsIn-Line—
17 July 2026Evercore ISI GroupMaintainsIn-Line$430 → $375
17 July 2026JP MorganMaintainsOverweight—
17 July 2026JP MorganMaintainsOverweight$550 → $450
17 July 2026Leerink PartnersMaintainsOutperform$573 → $454
17 July 2026Leerink PartnersMaintainsOutperform—
17 July 2026MizuhoMaintainsNeutral—
17 July 2026MizuhoMaintainsNeutral$500 → $400

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. ISRG appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Estimates

ISRG analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
EPS revision, 90 days
+3.7%
Analysts raising
23
Analysts cutting
0
Fundamentals

Intuitive Surgical, Inc. (ISRG) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
46.1×

Cheaper than 17% of US stocks

Price / sales
12.8×

Cheaper than 12% of US stocks

Price / book
7.7×

Cheaper than 14% of US stocks

EV / EBITDA
32.7×

Cheaper than 8% of US stocks

Growth & margins
Revenue growth (YoY)
18.5%

Higher than 68% of US stocks

Earnings growth (YoY)
24.3%

Higher than 63% of US stocks

Gross margin
67.8%

Higher than 81% of US stocks

Operating margin
33.6%

Higher than 89% of US stocks

Net margin
28.4%

Higher than 88% of US stocks

Returns & dividend
Return on equity
17.4%

Higher than 78% of US stocks

Return on assets
10.5%

Higher than 93% of US stocks

Dividend yield
—

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Peers

ISRG vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelMedical Instruments & Supplies
CompanyMarket capTKN rank
ISRGIntuitive Surgical, Inc.$141.3B
75
BDXBecton, Dickinson & Co.$50.5B
92
MDLNMedline, Inc.$47.0B
19
ALCAlcon AG$37.0B
69
RMDResMed, Inc.$32.8B
71
WSTWest Pharmaceutical Services, Inc.$25.1B
93
SOLVSolventum Corp.$15.4B
89

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own Intuitive Surgical, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest ISRG news & analysis

ISRG's US Procedure Growth Slows: Is ACA Headwind a Temporary Concern?

Zacks Investment Research · 12 Aug 2026positive

Intuitive Surgical's US procedure growth slowed in Q2, though the slowdown is attributed to ACA-related care deferrals that may be temporary. Underlying demand and adoption of the da Vinci 5 system remain strong.

Why it matters — ISRG watchers would track whether the Q2 procedure-growth slowdown is a short-term ACA deferral or a more lasting demand issue affecting the company's core US business.

Intuitive Surgical: Priced For Precision

Seeking Alpha · 12 Aug 2026neutral

Seeking Alpha rated Intuitive Surgical a Hold, modeling +9.17% upside with a price target of $426.65. The analysis centres on untapped ambulatory surgery centre (ASC) procedure volume and remanufacturing's role in expanding the installed base, noting remanufacturing poses limited threat with sub-3% penetration and approval for only 4 of 45+ instruments.

Why it matters — ISRG watchers would care because the piece frames a key debate over whether remanufacturing risk is overstated, seeing ASC growth and remanufacturing as drivers of installed-base expansion while keeping a cautious Hold stance.

This Intuitive Surgical Analyst Turns Bullish; Here Are Top 4 Upgrades For Wednesday

Benzinga · 12 Aug 2026positive

A Wall Street analyst reportedly turned bullish on Intuitive Surgical, with the company listed among the top four analyst upgrades for the day. The article notes that various top analysts changed their outlooks on these names, with full details available on an analyst ratings page.

Why it matters — An ISRG watcher would care because a bullish analyst rating change can signal shifting Wall Street sentiment toward the company.

Intuitive Surgical (ISRG) Stock Has Plunged 33% in 2026. Here's Why One Fund Manager Remains Bullish -- and Why I Do, Too.

The Motley Fool · 12 Aug 2026positive

The Motley Fool reports that despite Intuitive Surgical's stock falling 33% in 2026, one fund manager remains bullish on the robotic surgery specialist, which has over 12,000 installed systems globally and faces headwinds but retains strong fundamentals.

Why it matters — ISRG watchers would care because the article signals that despite a steep stock decline, some professional investors see long-term value in the company's installed base and market position.

The Number One Reason I Keep Buying Intuitive Surgical Now For The Long Run

24/7 Wall Street · 11 Aug 2026positive

The article explains why the author continues to accumulate Intuitive Surgical shares for the long term, noting that the recent drawdown strengthened rather than weakened their stance. The piece focuses on the author's persistent conviction in buying ISRG despite the pullback.

Why it matters — ISRG watchers would be interested in the rationale behind sustained long-term accumulation of the stock during its recent drawdown.

FAQ

Frequently asked questions about ISRG stock

What is the ISRG stock price forecast for 2026-2027?

The 33 Wall Street analysts covering Intuitive Surgical, Inc. have a median 12-month price target of $483, with estimates ranging from $324 to $685. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is ISRG stock a buy right now?

Of the 33 analysts covering Intuitive Surgical, Inc., 23 rate it a Buy, 9 a Hold and 1 a Sell. Ticker Nerd's systematic factor model ranks Intuitive Surgical, Inc. 75 out of 100 across roughly 4,600 US stocks as at 15 Aug 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank ISRG?

As at 15 Aug 2026, Intuitive Surgical, Inc. ranks 75 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Revisions (94 of 100).

Will ISRG stock go up?

No one can know that. What the data says: the median 12-month target from 33 analysts implies +22.4% from the last close, and Ticker Nerd's factor model ranks Intuitive Surgical, Inc. 75 out of 100 as at 15 Aug 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the ISRG stock forecast for 2030?

No analyst covering Intuitive Surgical, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for ISRG are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $324 to $685 over the next 12 months.

How has ISRG stock performed over the past year?

Intuitive Surgical, Inc. returned -17.3% over the 12 months to 14 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Intuitive Surgical, Inc. do?

Intuitive Surgical, Inc. is a medical technology company that develops, manufactures, and markets robotic-assisted systems designed to support minimally invasive care in hospitals and healthcare facilities worldwide.

What is the latest news on ISRG?

The most recent item we track (Zacks Investment Research, 12 Aug 2026): "ISRG's US Procedure Growth Slows: Is ACA Headwind a Temporary Concern?". Intuitive Surgical's US procedure growth slowed in Q2, though the slowdown is attributed to ACA-related care deferrals that may be temporary. Underlying demand and adoption of the da Vinci 5 system remain strong.

Company

About Intuitive Surgical, Inc.

Intuitive Surgical, Inc. is a medical technology company that develops, manufactures, and markets robotic-assisted systems designed to support minimally invasive care in hospitals and healthcare facilities worldwide. Its primary platforms include the da Vinci Surgical System, which enables surgeons to perform complex procedures through small incisions with enhanced precision, visualization, and control, and the Ion endoluminal system, which focuses on minimally invasive lung biopsies and diagnostic procedures. Intuitive Surgical provides a comprehensive ecosystem around these systems, including surgical instruments, disposable accessories, vision and imaging technologies, training, and technical support services. The company works closely with surgeons and healthcare providers across specialties such as urology, gynecology, general surgery, and thoracic care, aiming to broaden access to minimally invasive treatment options. Intuitive Surgical, Inc. was incorporated in 1995 and is headquartered in Sunnyvale, California.

CEO Mr. David J. Rosa · 17,021 employees · United States · https://www.intuitive.com